138 related articles for article (PubMed ID: 2019266)
21. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
Kirstein M; Baglioni C
J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
[TBL] [Abstract][Full Text] [Related]
22. Constitutive biosynthesis of bone Gla protein in a human osteosarcoma cell line.
Kaplan GC; Eilon G; Poser JW; Jacobs JW
Endocrinology; 1985 Sep; 117(3):1235-8. PubMed ID: 2410238
[TBL] [Abstract][Full Text] [Related]
23. Cytokine-induced inhibition of bone matrix proteins is not mediated by prostaglandins.
Rosenquist JB; Ohlin A; Lerner UH
Inflamm Res; 1996 Sep; 45(9):457-63. PubMed ID: 8891757
[TBL] [Abstract][Full Text] [Related]
24. Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells.
Long GJ; Rosen JF; Pounds JG
Toxicol Appl Pharmacol; 1990 Nov; 106(2):270-7. PubMed ID: 2256116
[TBL] [Abstract][Full Text] [Related]
25. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
26. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J
J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879
[TBL] [Abstract][Full Text] [Related]
27. Human osteoblast-like cells respond to mechanical strain with increased bone matrix protein production independent of hormonal regulation.
Harter LV; Hruska KA; Duncan RL
Endocrinology; 1995 Feb; 136(2):528-35. PubMed ID: 7530647
[TBL] [Abstract][Full Text] [Related]
28. Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro.
Taichman RS; Hauschka PV
Inflammation; 1992 Dec; 16(6):587-601. PubMed ID: 1459694
[TBL] [Abstract][Full Text] [Related]
29. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ
J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399
[TBL] [Abstract][Full Text] [Related]
30. 1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry.
Jowell PS; Epstein S; Fallon MD; Reinhardt TA; Ismail F
Endocrinology; 1987 Feb; 120(2):531-6. PubMed ID: 3492365
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro.
Barone LM; Aronow MA; Tassinari MS; Conlon D; Canalis E; Stein GS; Lian JB
J Cell Physiol; 1994 Aug; 160(2):255-64. PubMed ID: 8040186
[TBL] [Abstract][Full Text] [Related]
32. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3.
Nambi P; Wu HL; Lipshutz D; Prabhakar U
Mol Pharmacol; 1995 Feb; 47(2):266-71. PubMed ID: 7870034
[TBL] [Abstract][Full Text] [Related]
34. 1 alpha,25-dihydroxyvitamin D3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression.
Jenis LG; Lian JB; Stein GS; Baran DT
J Cell Biochem; 1993 Nov; 53(3):234-9. PubMed ID: 8263040
[TBL] [Abstract][Full Text] [Related]
35. Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone.
Bodine PV; Vernon SK; Komm BS
Endocrinology; 1996 Nov; 137(11):4592-604. PubMed ID: 8895322
[TBL] [Abstract][Full Text] [Related]
36. Regulatory effect of calcium-regulating hormones on the synthesis and/or secretion of bone gamma-carboxyglutamic acid-containing protein in chick embryonic calvaria in vitro.
Tsutsumi C; Hoshiba K; Moriuchi S; Orimo H; Hosoya N
J Nutr Sci Vitaminol (Tokyo); 1986 Apr; 32(2):157-69. PubMed ID: 3020205
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-1 modulates steroid hormone effects on osteocalcin synthesis in human MG-63 osteosarcoma cells.
Pirskanen A; Jääskeläinen T; Mäenpää PH
Eur J Biochem; 1993 Dec; 218(3):883-91. PubMed ID: 8281940
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of cadmium to rat osteosarcoma cells (ROS 17/2.8): protective effect of 1 alpha,25-dihydroxyvitamin D3.
Angle CR; Thomas DJ; Swanson SA
Toxicol Appl Pharmacol; 1990 Mar; 103(1):113-20. PubMed ID: 2315924
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of 1,25(OH)2 vitamin D3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts.
Broess M; Riva A; Gerstenfeld LC
J Cell Biochem; 1995 Mar; 57(3):440-51. PubMed ID: 7768979
[TBL] [Abstract][Full Text] [Related]
40. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
